Antenatal Steroids Effect on Mortality and Respiratory Outcomes in Preterm Infants
NCT ID: NCT04214795
Last Updated: 2020-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
710 participants
OBSERVATIONAL
2012-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antenatal Corticoid Therapy for Late Preterm Babies
NCT00675246
Prenatal Corticosteroids and Antioxidants in Preterm Infants
NCT00791687
Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants
NCT01206946
Rescue Antenatal Steroids and Pulmonary Function Tests in Preterm Infants
NCT00669383
Impact of Antenatal Corticosteroid Therapy on Postnatal Surfactant Use in Preterm Infants
NCT05455879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data are prospectively recorded. Perinatal variables (Gestational age, materna condition at admission, antenatal steroids treatment, gender and results of histological analysis of the placenta) are recorded as well as respiratory status during hospitalization and morbidities at discharge. Results of neurodevelopment test performed at 24 months of corrected age are also included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infants born after a complete course of antenatal steroids.
Preterm Infants born with less than 32 w GA whose mothers had received a complete course (two doses of celestone in the period between 24 hours and 7 days before delivery.
Observational study. Postnatal variables are recorded
Postnatal evolution is analyzed in both groups
Infants born without a complete course of antenatal steroids
Preterm Infants born with less than 32 w GA whose mothers did not received any dose of celestone or an uncompleted course (less than 24 hours or more than 7 days from delivery).
Observational study. Postnatal variables are recorded
Postnatal evolution is analyzed in both groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational study. Postnatal variables are recorded
Postnatal evolution is analyzed in both groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* premature infants in whom active resuscitation measures are not established.
6 Hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General Universitario Gregorio Marañon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manuel Sanchez Luna
Medical Doctor. Pediatric Profesor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel Sánchez-Luna, MD
Role: STUDY_DIRECTOR
Gregorio Marañón Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cristina Ramos-Navarro
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANS- 2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.